Paediatric Diseases Working Party (PDWP)
Study number:
Type of Stem Cell Treatment:
Diseases:
Short title:
Primary objective:
To report the outcomes of adult SCD patients undergoing allo-HSCT from an HLA-identical, related donor or haploidentical and unrelated donors, with the main end point being the successful engraftment and overall survival, disease free survival at a certain point in time.
Key inclusion criteria:
All consecutive SCD patients older than 17 years who underwent allo-HSCT between Jan 2010 and June 2020, regardless of conditioning will be included.
Country:
Principal investigator:
Can Boga
EBMT Study coordinator:
Arnaud Dalissier
Study coordinator email:
arnaud.dalissier@upmc.fr